Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-12-17

AUTHORS

M. C. G. Leite-Avalca, F. T. Staats, D. Verona, P. de Souza, M. C. Almeida, J. E. Silva-Santos, A. R. Zampronio

ABSTRACT

Sepsis is a life-threatening condition with high mortality rates that is caused by dysregulation of the host response to infection. We previously showed that treatment with the cannabinoid CB1 receptor antagonist rimonabant reduced mortality rates in animals with sepsis that was induced by cecal ligation and puncture (CLP). This improvement in the survival rate appeared to be related to an increase in arginine vasopressin (AVP) levels 12 h after CLP. The present study investigated the effects of rimonabant on organ dysfunction, hematologic parameters, and vascular reactivity in male Wistar rats with sepsis induced by CLP. Intraperitoneal treatment with rimonabant (10 mg/kg, 4 h after CLP) abolished the increase in the plasma levels of lactate, lactate dehydrogenase, glucose, and creatinine kinase MB without altering hematological parameters (i.e., leukopenia and a reduction of platelet counts). CLP increased plasma levels of nitrate/nitrite (NOx) and induced vasoconstriction in the tail artery. The treatment of CLP rats with rimonabant did not alter NOx production but reduced the vasoconstriction. Rimonabant also attenuated the hyperreactivity to AVP induced by CLP without affecting hyporesponsiveness to phenylephrine in aortic rings. These results suggest that rimonabant reduces organ dysfunction during sepsis, and this effect may be related to AVP signaling in blood vessels. This effect may have contributed to the higher survival rate in rimonabant-treated septic animals. More... »

PAGES

618-627

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10753-018-0919-z

DOI

http://dx.doi.org/10.1007/s10753-018-0919-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110684856

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30556096


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aorta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arginine Vasopressin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cannabinoid Receptor Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cecum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Organ Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitric Oxide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rimonabant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sepsis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasoconstriction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.20736.30", 
          "name": [
            "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leite-Avalca", 
        "givenName": "M. C. G.", 
        "id": "sg:person.013111570105.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013111570105.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.20736.30", 
          "name": [
            "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Staats", 
        "givenName": "F. T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.20736.30", 
          "name": [
            "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verona", 
        "givenName": "D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, Santa Catarina, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411237.2", 
          "name": [
            "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, Santa Catarina, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Souza", 
        "givenName": "P.", 
        "id": "sg:person.0673707157.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673707157.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Natural and Human Sciences, Federal University of ABC, S\u00e3o Bernardo do Campo, S\u00e3o Paulo, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.412368.a", 
          "name": [
            "Center for Natural and Human Sciences, Federal University of ABC, S\u00e3o Bernardo do Campo, S\u00e3o Paulo, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Almeida", 
        "givenName": "M. C.", 
        "id": "sg:person.01135055651.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135055651.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, Santa Catarina, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.411237.2", 
          "name": [
            "Department of Pharmacology, Federal University of Santa Catarina, Florian\u00f3polis, Santa Catarina, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Silva-Santos", 
        "givenName": "J. E.", 
        "id": "sg:person.01027605262.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027605262.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departamento de Farmacologia, Centro Polit\u00e9cnico, Universidade Federal do Paran\u00e1, Caixa Postal 19031, 81540-970, Curitiba, Paran\u00e1, Brazil", 
          "id": "http://www.grid.ac/institutes/grid.20736.30", 
          "name": [
            "Department of Pharmacology, Biological Sciences Section, Federal University of Paran\u00e1, Curitiba, Paran\u00e1, Brazil", 
            "Departamento de Farmacologia, Centro Polit\u00e9cnico, Universidade Federal do Paran\u00e1, Caixa Postal 19031, 81540-970, Curitiba, Paran\u00e1, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zampronio", 
        "givenName": "A. R.", 
        "id": "sg:person.01217132134.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217132134.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11011-007-9058-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028004896", 
          "https://doi.org/10.1007/s11011-007-9058-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2119/molmed.2015.00255", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068965816", 
          "https://doi.org/10.2119/molmed.2015.00255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2110-5820-3-12", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452959", 
          "https://doi.org/10.1186/2110-5820-3-12"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature01326", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033794061", 
          "https://doi.org/10.1038/nature01326"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12-17", 
    "datePublishedReg": "2018-12-17", 
    "description": "Sepsis is a life-threatening condition with high mortality rates that is caused by dysregulation of the host response to infection. We previously showed that treatment with the cannabinoid CB1 receptor antagonist rimonabant reduced mortality rates in animals with sepsis that was induced by cecal ligation and puncture (CLP). This improvement in the survival rate appeared to be related to an increase in arginine vasopressin (AVP) levels 12\u00a0h after CLP. The present study investigated the effects of rimonabant on organ dysfunction, hematologic parameters, and vascular reactivity in male Wistar rats with sepsis induced by CLP. Intraperitoneal treatment with rimonabant (10\u00a0mg/kg, 4\u00a0h after CLP) abolished the increase in the plasma levels of lactate, lactate dehydrogenase, glucose, and creatinine kinase MB without altering hematological parameters (i.e., leukopenia and a reduction of platelet counts). CLP increased plasma levels of nitrate/nitrite (NOx) and induced vasoconstriction in the tail artery. The treatment of CLP rats with rimonabant did not alter NOx production but reduced the vasoconstriction. Rimonabant also attenuated the hyperreactivity to AVP induced by CLP without affecting hyporesponsiveness to phenylephrine in aortic rings. These results suggest that rimonabant reduces organ dysfunction during sepsis, and this effect may be related to AVP signaling in blood vessels. This effect may have contributed to the higher survival rate in rimonabant-treated septic animals.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10753-018-0919-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2357110", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1084792", 
        "issn": [
          "0360-3997", 
          "1573-2576"
        ], 
        "name": "Inflammation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "organ dysfunction", 
      "vascular reactivity", 
      "plasma levels", 
      "mortality rate", 
      "survival rate", 
      "cannabinoid CB1 receptor antagonist", 
      "life-threatening condition", 
      "alters vascular reactivity", 
      "effects of rimonabant", 
      "CB1 receptor antagonist", 
      "male Wistar rats", 
      "high mortality rate", 
      "nitrate/nitrite", 
      "CLP rats", 
      "cecal ligation", 
      "septic animals", 
      "intraperitoneal treatment", 
      "tail artery", 
      "aortic rings", 
      "receptor antagonist", 
      "Wistar rats", 
      "hematologic parameters", 
      "late sepsis", 
      "sepsis", 
      "hematological parameters", 
      "aortic vessels", 
      "host response", 
      "Rimonabant", 
      "higher survival rate", 
      "dysfunction", 
      "decrease levels", 
      "blood vessels", 
      "levels 12", 
      "rats", 
      "CLP", 
      "lactate dehydrogenase", 
      "vasoconstriction", 
      "treatment", 
      "AVP", 
      "present study", 
      "animals", 
      "vessels", 
      "hyperreactivity", 
      "hyporesponsiveness", 
      "creatinine", 
      "artery", 
      "antagonist", 
      "puncture", 
      "infection", 
      "levels", 
      "rate", 
      "dysregulation", 
      "ligation", 
      "effect", 
      "markers", 
      "lactate", 
      "increase", 
      "glucose", 
      "arginine", 
      "reactivity", 
      "response", 
      "study", 
      "dehydrogenase", 
      "improvement", 
      "NOx production", 
      "nitrite", 
      "production", 
      "results", 
      "parameters", 
      "conditions", 
      "MB", 
      "ring", 
      "rimonabant reduces organ dysfunction", 
      "reduces organ dysfunction", 
      "rimonabant-treated septic animals", 
      "Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels", 
      "CB1 Receptor Antagonist Rimonabant Decreases Levels", 
      "Receptor Antagonist Rimonabant Decreases Levels", 
      "Antagonist Rimonabant Decreases Levels", 
      "Rimonabant Decreases Levels"
    ], 
    "name": "Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats", 
    "pagination": "618-627", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110684856"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10753-018-0919-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30556096"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10753-018-0919-z", 
      "https://app.dimensions.ai/details/publication/pub.1110684856"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_759.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10753-018-0919-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10753-018-0919-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10753-018-0919-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10753-018-0919-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10753-018-0919-z'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      22 PREDICATES      126 URIs      114 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10753-018-0919-z schema:about N17ddf9e8bc7a4106a0a009999a45577d
2 N3399c5e87ad44246a441d9494ff4c9d1
3 N3f40d89f619c4c17a85846e61cb43cd5
4 N4cf0914432bc407ea6539c136d1bb092
5 N5d885bac78a042edbbb8d6cad5af318b
6 N7617c8b2e5434071b78a2919b64dc113
7 N7d46a98c079f4076b7865a29f295ffd4
8 N9404a07620ed4d68880479ae7e0a5af8
9 N9892d8a64e7641fd939399093b9050b6
10 Na2a5b138ccbe4d4183f172a9cd778dd0
11 Na317bd61bb7343b8a720ef6a17a4bfcb
12 Nac23a637a9a849f399b283848212f9ee
13 Nbb645bfbea8c4974bc040e73c2301c28
14 Nbd4e2de9422248689ba8290589860dcb
15 Nec1ccf64fee4464c9efaafbefda61ff7
16 Nf636525db557410ab87b5f842dd90df8
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N4d473c50df544b2aab917626c3839535
20 schema:citation sg:pub.10.1007/s11011-007-9058-1
21 sg:pub.10.1038/nature01326
22 sg:pub.10.1186/2110-5820-3-12
23 sg:pub.10.2119/molmed.2015.00255
24 schema:datePublished 2018-12-17
25 schema:datePublishedReg 2018-12-17
26 schema:description Sepsis is a life-threatening condition with high mortality rates that is caused by dysregulation of the host response to infection. We previously showed that treatment with the cannabinoid CB1 receptor antagonist rimonabant reduced mortality rates in animals with sepsis that was induced by cecal ligation and puncture (CLP). This improvement in the survival rate appeared to be related to an increase in arginine vasopressin (AVP) levels 12 h after CLP. The present study investigated the effects of rimonabant on organ dysfunction, hematologic parameters, and vascular reactivity in male Wistar rats with sepsis induced by CLP. Intraperitoneal treatment with rimonabant (10 mg/kg, 4 h after CLP) abolished the increase in the plasma levels of lactate, lactate dehydrogenase, glucose, and creatinine kinase MB without altering hematological parameters (i.e., leukopenia and a reduction of platelet counts). CLP increased plasma levels of nitrate/nitrite (NOx) and induced vasoconstriction in the tail artery. The treatment of CLP rats with rimonabant did not alter NOx production but reduced the vasoconstriction. Rimonabant also attenuated the hyperreactivity to AVP induced by CLP without affecting hyporesponsiveness to phenylephrine in aortic rings. These results suggest that rimonabant reduces organ dysfunction during sepsis, and this effect may be related to AVP signaling in blood vessels. This effect may have contributed to the higher survival rate in rimonabant-treated septic animals.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N6d303823964d4b089732258592a2624f
31 N99a1600fda69477183e4d85da61c91b0
32 sg:journal.1084792
33 schema:keywords AVP
34 Antagonist Rimonabant Decreases Levels
35 CB1 Receptor Antagonist Rimonabant Decreases Levels
36 CB1 receptor antagonist
37 CLP
38 CLP rats
39 Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels
40 MB
41 NOx production
42 Receptor Antagonist Rimonabant Decreases Levels
43 Rimonabant
44 Rimonabant Decreases Levels
45 Wistar rats
46 alters vascular reactivity
47 animals
48 antagonist
49 aortic rings
50 aortic vessels
51 arginine
52 artery
53 blood vessels
54 cannabinoid CB1 receptor antagonist
55 cecal ligation
56 conditions
57 creatinine
58 decrease levels
59 dehydrogenase
60 dysfunction
61 dysregulation
62 effect
63 effects of rimonabant
64 glucose
65 hematologic parameters
66 hematological parameters
67 high mortality rate
68 higher survival rate
69 host response
70 hyperreactivity
71 hyporesponsiveness
72 improvement
73 increase
74 infection
75 intraperitoneal treatment
76 lactate
77 lactate dehydrogenase
78 late sepsis
79 levels
80 levels 12
81 life-threatening condition
82 ligation
83 male Wistar rats
84 markers
85 mortality rate
86 nitrate/nitrite
87 nitrite
88 organ dysfunction
89 parameters
90 plasma levels
91 present study
92 production
93 puncture
94 rate
95 rats
96 reactivity
97 receptor antagonist
98 reduces organ dysfunction
99 response
100 results
101 rimonabant reduces organ dysfunction
102 rimonabant-treated septic animals
103 ring
104 sepsis
105 septic animals
106 study
107 survival rate
108 tail artery
109 treatment
110 vascular reactivity
111 vasoconstriction
112 vessels
113 schema:name Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats
114 schema:pagination 618-627
115 schema:productId N5ba8110a937e4c3b978f25acdc926729
116 Na0854079f2734451851dbaf57f4c332b
117 Ne02d6e35c7ae4bd29af9516eadf4d06f
118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110684856
119 https://doi.org/10.1007/s10753-018-0919-z
120 schema:sdDatePublished 2021-12-01T19:42
121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
122 schema:sdPublisher N274af8691a5f4a1cbfcd14be5a432f1b
123 schema:url https://doi.org/10.1007/s10753-018-0919-z
124 sgo:license sg:explorer/license/
125 sgo:sdDataset articles
126 rdf:type schema:ScholarlyArticle
127 N07ba8d915adb448db6ef22104287604b schema:affiliation grid-institutes:grid.20736.30
128 schema:familyName Verona
129 schema:givenName D.
130 rdf:type schema:Person
131 N0d10e6796c14428aa1587e2102d597c7 rdf:first sg:person.01135055651.66
132 rdf:rest N95848fe6544146f697f5bea53a4d2421
133 N17ddf9e8bc7a4106a0a009999a45577d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Cannabinoid Receptor Antagonists
135 rdf:type schema:DefinedTerm
136 N1d44338737be4d0a8b8be290cbf88336 rdf:first N87145f84cf084b2ca4e971fcf5bc6fe5
137 rdf:rest Nc43b58616695426db53d2d4a40c83406
138 N274af8691a5f4a1cbfcd14be5a432f1b schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 N3399c5e87ad44246a441d9494ff4c9d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Survival Rate
142 rdf:type schema:DefinedTerm
143 N3f40d89f619c4c17a85846e61cb43cd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Aorta
145 rdf:type schema:DefinedTerm
146 N4cf0914432bc407ea6539c136d1bb092 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Cecum
148 rdf:type schema:DefinedTerm
149 N4d473c50df544b2aab917626c3839535 rdf:first sg:person.013111570105.36
150 rdf:rest N1d44338737be4d0a8b8be290cbf88336
151 N5ba8110a937e4c3b978f25acdc926729 schema:name doi
152 schema:value 10.1007/s10753-018-0919-z
153 rdf:type schema:PropertyValue
154 N5d885bac78a042edbbb8d6cad5af318b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Male
156 rdf:type schema:DefinedTerm
157 N6d303823964d4b089732258592a2624f schema:volumeNumber 42
158 rdf:type schema:PublicationVolume
159 N6f3f57554d8d490c88997ea9a65404b9 rdf:first sg:person.0673707157.51
160 rdf:rest N0d10e6796c14428aa1587e2102d597c7
161 N7617c8b2e5434071b78a2919b64dc113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Sepsis
163 rdf:type schema:DefinedTerm
164 N7d46a98c079f4076b7865a29f295ffd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Arginine Vasopressin
166 rdf:type schema:DefinedTerm
167 N87145f84cf084b2ca4e971fcf5bc6fe5 schema:affiliation grid-institutes:grid.20736.30
168 schema:familyName Staats
169 schema:givenName F. T.
170 rdf:type schema:Person
171 N9404a07620ed4d68880479ae7e0a5af8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Hemodynamics
173 rdf:type schema:DefinedTerm
174 N95848fe6544146f697f5bea53a4d2421 rdf:first sg:person.01027605262.23
175 rdf:rest N9b60747985714d7cb8cf9ee16ce99b8d
176 N9892d8a64e7641fd939399093b9050b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Multiple Organ Failure
178 rdf:type schema:DefinedTerm
179 N99a1600fda69477183e4d85da61c91b0 schema:issueNumber 2
180 rdf:type schema:PublicationIssue
181 N9b60747985714d7cb8cf9ee16ce99b8d rdf:first sg:person.01217132134.96
182 rdf:rest rdf:nil
183 Na0854079f2734451851dbaf57f4c332b schema:name dimensions_id
184 schema:value pub.1110684856
185 rdf:type schema:PropertyValue
186 Na2a5b138ccbe4d4183f172a9cd778dd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Rats
188 rdf:type schema:DefinedTerm
189 Na317bd61bb7343b8a720ef6a17a4bfcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Vasoconstriction
191 rdf:type schema:DefinedTerm
192 Nac23a637a9a849f399b283848212f9ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Rimonabant
194 rdf:type schema:DefinedTerm
195 Nbb645bfbea8c4974bc040e73c2301c28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Rats, Wistar
197 rdf:type schema:DefinedTerm
198 Nbd4e2de9422248689ba8290589860dcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Animals
200 rdf:type schema:DefinedTerm
201 Nc43b58616695426db53d2d4a40c83406 rdf:first N07ba8d915adb448db6ef22104287604b
202 rdf:rest N6f3f57554d8d490c88997ea9a65404b9
203 Ne02d6e35c7ae4bd29af9516eadf4d06f schema:name pubmed_id
204 schema:value 30556096
205 rdf:type schema:PropertyValue
206 Nec1ccf64fee4464c9efaafbefda61ff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Nitric Oxide
208 rdf:type schema:DefinedTerm
209 Nf636525db557410ab87b5f842dd90df8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Signal Transduction
211 rdf:type schema:DefinedTerm
212 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
213 schema:name Medical and Health Sciences
214 rdf:type schema:DefinedTerm
215 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
216 schema:name Clinical Sciences
217 rdf:type schema:DefinedTerm
218 sg:grant.2357110 http://pending.schema.org/fundedItem sg:pub.10.1007/s10753-018-0919-z
219 rdf:type schema:MonetaryGrant
220 sg:journal.1084792 schema:issn 0360-3997
221 1573-2576
222 schema:name Inflammation
223 schema:publisher Springer Nature
224 rdf:type schema:Periodical
225 sg:person.01027605262.23 schema:affiliation grid-institutes:grid.411237.2
226 schema:familyName Silva-Santos
227 schema:givenName J. E.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027605262.23
229 rdf:type schema:Person
230 sg:person.01135055651.66 schema:affiliation grid-institutes:grid.412368.a
231 schema:familyName Almeida
232 schema:givenName M. C.
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135055651.66
234 rdf:type schema:Person
235 sg:person.01217132134.96 schema:affiliation grid-institutes:grid.20736.30
236 schema:familyName Zampronio
237 schema:givenName A. R.
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217132134.96
239 rdf:type schema:Person
240 sg:person.013111570105.36 schema:affiliation grid-institutes:grid.20736.30
241 schema:familyName Leite-Avalca
242 schema:givenName M. C. G.
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013111570105.36
244 rdf:type schema:Person
245 sg:person.0673707157.51 schema:affiliation grid-institutes:grid.411237.2
246 schema:familyName de Souza
247 schema:givenName P.
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673707157.51
249 rdf:type schema:Person
250 sg:pub.10.1007/s11011-007-9058-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028004896
251 https://doi.org/10.1007/s11011-007-9058-1
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/nature01326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033794061
254 https://doi.org/10.1038/nature01326
255 rdf:type schema:CreativeWork
256 sg:pub.10.1186/2110-5820-3-12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002452959
257 https://doi.org/10.1186/2110-5820-3-12
258 rdf:type schema:CreativeWork
259 sg:pub.10.2119/molmed.2015.00255 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068965816
260 https://doi.org/10.2119/molmed.2015.00255
261 rdf:type schema:CreativeWork
262 grid-institutes:grid.20736.30 schema:alternateName Departamento de Farmacologia, Centro Politécnico, Universidade Federal do Paraná, Caixa Postal 19031, 81540-970, Curitiba, Paraná, Brazil
263 Department of Pharmacology, Biological Sciences Section, Federal University of Paraná, Curitiba, Paraná, Brazil
264 schema:name Departamento de Farmacologia, Centro Politécnico, Universidade Federal do Paraná, Caixa Postal 19031, 81540-970, Curitiba, Paraná, Brazil
265 Department of Pharmacology, Biological Sciences Section, Federal University of Paraná, Curitiba, Paraná, Brazil
266 rdf:type schema:Organization
267 grid-institutes:grid.411237.2 schema:alternateName Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil
268 schema:name Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil
269 rdf:type schema:Organization
270 grid-institutes:grid.412368.a schema:alternateName Center for Natural and Human Sciences, Federal University of ABC, São Bernardo do Campo, São Paulo, Brazil
271 schema:name Center for Natural and Human Sciences, Federal University of ABC, São Bernardo do Campo, São Paulo, Brazil
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...